CAR-T

| CRISPR Medicine | This is an overview of articles on CAR-T

Sign-up to weekly Newsletter here.

CRISPR Enhances CAR T-Cell Cancer Therapies

Jul. 23, 2024

Using CRISPR-Cas9 to knock out CD5, researchers have significantly improved the efficacy of adoptive T-cell therapies for both haematological and...

Clinical Trial Updates From the Gene-Editing Field...

CMN Clinical

Mar. 27, 2024

In this update, we highlight recent news on Poseida Therapeutics' fully allogeneic CAR-T candidate for multiple myeloma (P-BCMA-ALLO1), Intellia's and...

Clinical Update: Dosing Underway in Trial of First...

CMN Clinical

Mar. 6, 2024

AvenCell Therapeutics recently announced that the first patient has been dosed in a Phase 1A study with its lead product candidate AVC-201. This novel...

Safe and Precise CAR Integration

Feb. 20, 2024

Using CRISPR to Improve CAR-T Cells

Feb. 12, 2024

CRISPR and Universal CAR-T cells

Feb. 4, 2024

CAR-T cells: a Shift in Cancer Immunotherapy

Jan. 24, 2024

Fate Therapeutics Initiates Phase 1 Trial in...

CMN Clinical

Jan. 10, 2024

Fate Therapeutics announced this week that enrolment is underway for a Phase 1 trial of FT-825/OMO-8250 in advanced HER2-expressing solid tumours.